Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel "two-in-one" antibody targeting EGFR/HER3 shows preclinical potential

May 11, 2010

Orchid Chemicals & Pharmaceuticals describes novel HDAC inhibitors

May 11, 2010

PRISM Biolab identifies novel Wnt signaling pathway inhibitors

May 11, 2010

Aeterna Zentaris receives FDA orphan drug status for AEZS-108 in ovarian cancer

May 10, 2010

Bayer Schering Pharma begins phase III regorafenib trial in mCRC

May 10, 2010

MediGene reports results from phase II clinical trial of EndoTAG-1 in breast cancer

May 10, 2010

Novel LNA-based antisense oligonucleotides show potent antitumor effects in vivo

May 10, 2010

Dual PDK1/AKT inhibitor PHT-427 identified through PHuDock platform

May 10, 2010

Next-generation sequencing analysis identifies gene mutations affecting response to panitumumab

May 10, 2010

Cequent describes IND-enabling studies of RNAi drug for adenomatous polyposis

May 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.